These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8300049)

  • 41. Control of the transcription of the growth hormone-releasing hormone and somatostatin genes by sex steroids.
    Argente J; Chowen JA
    Horm Res; 1993; 40(1-3):48-53. PubMed ID: 7905456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
    Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
    Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of season and nutrition on growth hormone and insulin-like growth factor-I in male red deer.
    Webster JR; Corson ID; Littlejohn RP; Stuart SK; Suttie JM
    Endocrinology; 1996 Feb; 137(2):698-704. PubMed ID: 8593820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.
    Lamberts SW; den Holder F; Hofland LJ
    Endocrinology; 1989 Feb; 124(2):905-11. PubMed ID: 2492219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ontogeny of GH mRNA and GH secretion in male and female rats: regulation by GH-releasing hormone.
    Hu Z; Friberg RD; Barkan AL
    Am J Physiol; 1993 Aug; 265(2 Pt 1):E236-42. PubMed ID: 8368293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal structure of in vivo growth hormone secretory events in humans.
    Hartman ML; Faria AC; Vance ML; Johnson ML; Thorner MO; Veldhuis JD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):E101-10. PubMed ID: 1987784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered secretion of growth hormone and luteinizing hormone after 84 h of sustained physical exertion superimposed on caloric and sleep restriction.
    Nindl BC; Rarick KR; Castellani JW; Tuckow AP; Patton JF; Young AJ; Montain SJ
    J Appl Physiol (1985); 2006 Jan; 100(1):120-8. PubMed ID: 16141374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone.
    Van Cauter E; Caufriez A; Kerkhofs M; Van Onderbergen A; Thorner MO; Copinschi G
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1451-9. PubMed ID: 1592893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty.
    Mauras N; Rogol AD; Haymond MW; Veldhuis JD
    Horm Res; 1996; 45(1-2):74-80. PubMed ID: 8742123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
    Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO
    J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
    Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR
    Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay.
    Veldhuis JD; Liem AY; South S; Weltman A; Weltman J; Clemmons DA; Abbott R; Mulligan T; Johnson ML; Pincus S
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3209-22. PubMed ID: 7593428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.
    Tannenbaum GS; Bowers CY
    Endocrine; 2001 Feb; 14(1):21-7. PubMed ID: 11322498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes.
    Thomas GB; Cummins JT; Francis H; Sudbury AW; McCloud PI; Clarke IJ
    Endocrinology; 1991 Feb; 128(2):1151-8. PubMed ID: 1671214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men.
    Hartman ML; Veldhuis JD; Johnson ML; Lee MM; Alberti KG; Samojlik E; Thorner MO
    J Clin Endocrinol Metab; 1992 Apr; 74(4):757-65. PubMed ID: 1548337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ovariectomy during the luteal phase influences secretion of prolactin, growth hormone, and insulin-like growth factor-I in the bitch.
    Lee WM; Kooistra HS; Mol JA; Dieleman SJ; Schaefers-Okkens AC
    Theriogenology; 2006 Jul; 66(2):484-90. PubMed ID: 16442609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The GH/IGF-I axis in puberty.
    Loche S; Casini MR; Faedda A
    Br J Clin Pract Suppl; 1996 Aug; 85():1-4. PubMed ID: 8995016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.